Related Experiment Video
Updated: Nov 3, 2025
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
[Glioblastoma]
D H Martin1, E Bianchi2, S Ben Mustapha3
1Service de Neurochirurgie, CHU Liège, Belgique.
Abstract:
Glioblastoma is the most common primary malignant brain tumor. Despite treatments combining excisional surgery, chemotherapy, and radiotherapy, overall survival remains low and the incidence of tumor recurrence remains high. Advances in the understanding of the disease, particularly its molecular biology and the mechanisms of action of systemic and radiotherapeutic treatments, as well as the development of image-guided surgical techniques, offer hope for the control of this hitherto incurable disease.
Insights
Glioblastoma, a common brain cancer, has poor survival rates despite current treatments. New insights into its molecular biology and surgical techniques offer hope for better control and reduced recurrence.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Surgical Innovation
Background:
- Glioblastoma is the most frequent primary malignant brain tumor.
- Current treatment protocols (surgery, chemotherapy, radiotherapy) yield limited survival benefits and high recurrence rates.
Purpose of the Study:
- To highlight recent advances in understanding glioblastoma.
- To discuss improvements in treatment modalities and surgical approaches.
Main Methods:
- Review of current glioblastoma treatment strategies.
- Analysis of emerging research in molecular biology.
- Evaluation of advancements in image-guided surgical techniques.
Main Results:
- Limited efficacy of existing glioblastoma treatments.
- Progress in understanding tumor molecular mechanisms.
- Development of enhanced surgical precision.
Conclusions:
- Despite challenges, glioblastoma treatment is evolving.
- Advances in molecular understanding and surgical technology offer improved therapeutic prospects.
- Future strategies aim to enhance glioblastoma control and patient survival.
